Yeah I tend to agree... something is not sitting right at the moment. Why isn't biota doing a roadshow showing off the renewed interest in relenza and opportunities for LANI.
A few things come to mind... and poor results in RSV/HRV is a maybe. On the other hand they might be in "sensitive" times with regards to licencing and hence the restrained views expressed.
We'll find out all in a few months, getting pretty exciting now that LANI is weeks away from announcing phase III.
- Forums
- ASX - By Stock
- BTA
- anyone else expecting hrv trial to fail
anyone else expecting hrv trial to fail, page-5
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online